Abiomed (ABMD) Upgraded to Buy: What Does It Mean for the Stock?
Abiomed (ABMD) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates — one of the most powerful forces impacting stock prices. The sole determinant of the Zacks rating is a company's changing earnings picture […]